SCHEMBL5028270

SCHEMBL5028270

Cc1nnccc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29743790 0.97
Hydrochloric Acid SCHEMBL21597127 0.97
SCHEMBL29770643 0.72
SCHEMBL1050861 0.72
SCHEMBL15784152 0.72 ATR (0.40)
SCHEMBL2044973 0.70
Ammonia Solution, Strong SCHEMBL20338348 0.70
Hydrochloric Acid SCHEMBL10675414 0.70
Hydrochloric Acid SCHEMBL28430002 0.70
SCHEMBL24924051 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101541762-A Pyridazin-4-ylmethyl-sulfonamide compounds as fungicides and against arthropods BASF SE (DE) 2009-09-23 CN claimed
EP-4655069-A1 PYRIDAZINES AS SARM1 INHIBITORS Disarm Therapeutics, Inc. (US) 2025-12-03 EP disclosed
US-20250195480-A1 MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Fulcrum Therapeutics, Inc. 2025-06-19 US disclosed
US-20240425478-A1 CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS GENENTECH INC (US) 2024-12-26 US disclosed
US-12109198-B2 Macrocyclic azolopyridine derivatives as EED and PRC2 modulators Fulcrum Therapeutics, Inc. (US) 2024-10-08 US disclosed
EP-4412995-A1 CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS Genentech, Inc. (US) 2024-08-14 EP disclosed
WO-2024158775-A1 PYRIDAZINES AS SARM1 INHIBITORS DISARM THERAPEUTICS, INC. (US) 2024-08-02 WO disclosed
CN-118019734-A Cyclopentyl pyrazole CDK2 inhibitors 基因泰克公司 2024-05-10 CN disclosed
US-20240139163-A1 MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Fulcrum Therapeutics, Inc. 2024-05-02 US disclosed
CN-114144230-B Macrocyclic azolopyridine derivatives as EED and PRC2 modulators 弗尔康医疗公司 2024-04-23 CN disclosed
US-20200360353-A1 MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Fulcrum Therapeutics, Inc. 2020-11-19 US disclosed
US-20200360353-A1 MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Fulcrum Therapeutics, Inc. 2020-11-19 US disclosed
WO-2020190754-A1 MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Fulcrum Therapeutics, Inc. (US) 2020-09-24 WO disclosed
US-20180159051-A1 EMITTERS BASED ON OCTAHEDRAL METAL COMPLEXES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2018-06-07 US disclosed
CN-104703982-B Pyrazole compound and the pesticide combination comprising pyrazole compound 巴斯夫欧洲公司 2018-01-05 CN disclosed
WO-2016162325-A1 SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-A]PYRAZIN-1 (2H)-ONE DERIVATIVES AS KINASE INHIBITORS ASTRAZENECA AB (SE) 2016-10-13 WO disclosed
CN-103261210-B Metal complex 默克专利有限公司 2016-08-10 CN disclosed
CN-103261210-A Metal complexes MERCK PATENT GMBH 2013-08-21 CN disclosed
EP-2453496-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2012-05-16 EP disclosed
WO-2011050160-A1 PHARMACEUTICALS, COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME BIOGEN IDEC MA INC. (US) 2011-04-28 WO disclosed